Meeting
2014 Gastrointestinal Cancers Symposium
Prevalence of detectable HBV DNA in cancer patients with resolved HBV infection (HBsAg (-) HBcAb (+) and its evolution after cytotoxic chemotherapy.
Authors
Taral Ramesh Shah
Maimonides Medical Center, Brooklyn, NY
Taral Ramesh Shah , Huo Xiang Zheng , Pouyan Gohari , Maxim Shulimovich , Yiwu Huang , Yiqing Xu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 32, 2014 (suppl 3; abstr 194)
DOI
10.1200/jco.2014.32.3_suppl.194
Abstract #
194
Poster Bd #
A23
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Quality Care Symposium
Hepatitis B reactivation in patients with solid tumors: A systematic review and meta-analysis.
First Author: Lisa K. Hicks
Poster
2013 ASCO Quality Care Symposium
Hepatitis B reactivation in patients with lymphoma: A meta-analysis.
First Author: Lee Mozessohn
Poster
2020 Gastrointestinal Cancers Symposium
Impact of baseline hepatitis B viremia and management on outcomes in patients (Pts) with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP): Outcomes from REACH-2.
First Author: Peter R. Galle
Poster
2019 ASCO Quality Care Symposium
A cost-effectiveness analysis of primary prophylaxis (PP) versus secondary prophylaxis (SP) with biosimilar myeloid growth factors (MGFs) for preventing chemotherapy-induced febrile neutropenia (FN) in non-Hodgkin lymphoma (NHL) patients at intermediate risk.
First Author: Gary H. Lyman